First Wave BioPharma (NASDAQ:FWBI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Monday, Benzinga reports. Separately, Roth Mkm cut their price target on First Wave BioPharma from $40.00 to $36.00 and set a “buy” rating on the stock in a report […]
First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 176,600 shares, an increase of 39.7% from the January 15th total of 126,400 shares. Approximately 28.7% of the company’s stock are sold short. Based on […]
First Wave BioPharma, Inc. (NASDAQ:FWBI – Get Rating) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 55,700 shares, a growth of 19.8% from the April 30th total of 46,500 shares. Currently, 3.1% of the shares of the company are […]